Immunological Role of Soluble CD163 and CD248 Biomarkers in Insulin Resistance among Healthy Iraqi Adults

Document Type : New and original researches in the field of Microbiology.

Authors

1 Department of Biology, College of Sciences, University of Tikrit, Tikrit, Iraq.

2 Veterinary Medicine, University of Tikrit, Tikrit, Iraq

3 Medical Research Unit, College of Medicine, University of Al-Nahrain, Baghdad, Iraq

Abstract

Background: Insulin resistance (IR) is a major metabolic disturbance with associations with inflammation and impaired glucose homeostasis. Soluble CD163 and soluble CD248 are stroma- and macrophage-derived molecules that could bridge immune activation and insulin resistance. Objective: The present study was conducted to identify the serum levels of sCD163 and sCD248, and their association with insulin resistance in apparently healthy Iraqi adults. Methodology: A cross-sectional study was undertaken on 98 euglycemic non-diabetic adults (≥45 years). Participants were categorized according to HOMA-IR values (≤3 = insulin-sensitive, >3 = insulin-resistant). Anthropometric and biochemical parameters were measured, and serum concentrations of sCD163 and sCD248 were determined with ELISA kits. Results: Insulin resistance was present in 25 patients (25.5%). Both sCD163 and sCD248 concentrations were higher in IR individuals than in insulin-sensitive individuals (p < 0.05). Both biomarkers were found to be positively correlated with HOMA-IR and fasting insulin, indicating their implication in metabolic inflammation. Conclusion: Elevated serum sCD163 and sCD248 can serve as an early immunological indicator of insulin resistance in apparently healthy individuals. Monitoring them might be helpful in identifying subclinical metabolic risk.

Keywords

Main Subjects